CIK 0001672619 · Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811523849
- Phone
- 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF OPERATING OFFICER acquired 20,000 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 18,750 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 25,000 shares (grant or award)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $29.04 ($145,219)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 20,000 shares at an average $26.75 ($535,099)
- 4 Planned sale Director sold 1,230 shares at an average $26.75 ($32,902)
- 144 Insider Sale of Securities
Page 5 of 40 · 798 filings